On the other hand, in pancreatic cancer, the upregulation of SMARCA2 associates with disease progression, being significantly positively correlated with patients’ poor survival, larger tumor size, metastases, lymphatic invasion, and stage IV disease [131]. The gene discussed is SMARCA2; the disease is neoplasm.